Home » Iran’s Pharmaceutical Infrastructure Suffers Devastating Blow from US-Israeli Strike

Iran’s Pharmaceutical Infrastructure Suffers Devastating Blow from US-Israeli Strike

Reports have emerged of a US-Israeli assault on a critical Iranian pharmaceutical facility, with far-reaching implications for the country’s medical supply chain.
Iran’s official news agency, IRNA, has confirmed the target as the Tofigh Daru pharmaceutical raw material units in Tehran, a site of significant importance to the nation’s healthcare sector.
Deputy Health Minister Mahdi Pirsalehi revealed that the attack had left the production units and research and development department in complete ruins, as per IRNA’s account.
Although the factory did not manufacture finished medications, it played a pivotal role in producing essential raw materials for hospital medications, surgical equipment, and certain anti-cancer treatments, Pirsalehi explained.
The attack has been described by Pirsalehi as a severe setback for Iran’s medical supply chain.
Iran’s Foreign Ministry spokesperson, Esmaeil Baghaei, has strongly condemned the strike, labelling it a “heinous act of aggression and a grave breach of human rights”.
The Israeli military had previously claimed responsibility for the strike, stating that it targeted a research facility which systematically supplied the Iranian government with chemical substances.
The Israeli military alleged that the facility, owned by Tofigh Daru, served as a primary supplier of specialized substances to the SPND organization, which it accuses of being responsible for developing chemical weapons on behalf of the Iranian government.
However, the Israeli military failed to provide any concrete evidence to support its claims.

Skardu.pk is one of the leading authentic news and information platform focusing on adventure tourism, regional and world affairs.